Correlation Between Biomea Fusion and Rani Therapeutics
Can any of the company-specific risk be diversified away by investing in both Biomea Fusion and Rani Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomea Fusion and Rani Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomea Fusion and Rani Therapeutics Holdings, you can compare the effects of market volatilities on Biomea Fusion and Rani Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomea Fusion with a short position of Rani Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomea Fusion and Rani Therapeutics.
Diversification Opportunities for Biomea Fusion and Rani Therapeutics
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Biomea and Rani is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Biomea Fusion and Rani Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rani Therapeutics and Biomea Fusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomea Fusion are associated (or correlated) with Rani Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rani Therapeutics has no effect on the direction of Biomea Fusion i.e., Biomea Fusion and Rani Therapeutics go up and down completely randomly.
Pair Corralation between Biomea Fusion and Rani Therapeutics
Given the investment horizon of 90 days Biomea Fusion is expected to under-perform the Rani Therapeutics. In addition to that, Biomea Fusion is 1.03 times more volatile than Rani Therapeutics Holdings. It trades about -0.03 of its total potential returns per unit of risk. Rani Therapeutics Holdings is currently generating about -0.01 per unit of volatility. If you would invest 495.00 in Rani Therapeutics Holdings on August 31, 2024 and sell it today you would lose (293.00) from holding Rani Therapeutics Holdings or give up 59.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomea Fusion vs. Rani Therapeutics Holdings
Performance |
| Timeline |
| Biomea Fusion |
| Rani Therapeutics |
Biomea Fusion and Rani Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomea Fusion and Rani Therapeutics
The main advantage of trading using opposite Biomea Fusion and Rani Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomea Fusion position performs unexpectedly, Rani Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rani Therapeutics will offset losses from the drop in Rani Therapeutics' long position.| Biomea Fusion vs. Edgewise Therapeutics | Biomea Fusion vs. Werewolf Therapeutics | Biomea Fusion vs. Cullinan Oncology LLC | Biomea Fusion vs. Design Therapeutics |
| Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |